Gene · 5154
Papers4,148
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 4,148
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ROCK2, a critical regulator of immune modulation and fibrosis has emerged as a therapeutic target in chronic graft-versus-host disease. | Clin Immunol | 2021 | 34400321 | PubTator, text mining | PubMed |
| Epigenetic signatures differentiate uterine and soft tissue leiomyosarcoma. | Oncotarget | 2021 | 34381562 | PubTator, text mining | PubMed |
| Telocytes promote hepatocellular carcinoma by activating the ERK signaling pathway and miR-942-3p/MMP9 axis. | Cell Death Discov | 2021 | 34376644 | PubTator, text mining | PubMed |
| Differential Angiogenic Potential of 3-Dimension Spheroid of HNSCC Cells in Mouse Xenograft. | Int J Mol Sci | 2021 | 34361027 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell-Based Therapy as an Alternative to the Treatment of Acute Respiratory Distress Syndrome: Current Evidence and Future Perspectives. | Int J Mol Sci | 2021 | 34360616 | PubTator, text mining | PubMed |
| A Switch from Cell-Associated to Soluble PDGF-B Protects against Atherosclerosis, despite Driving Extramedullary Hematopoiesis. | Cells | 2021 | 34359916 | PubTator, text mining | PubMed |
| Extracellular Vesicles Derived from Endothelial Progenitor Cells Protect Human Glomerular Endothelial Cells and Podocytes from Complement- and Cytokine-Mediated Injury. | Cells | 2021 | 34359843 | PubTator, text mining | PubMed |
| The Emerging Factors and Treatment Options for NAFLD-Related Hepatocellular Carcinoma. | Cancers (Basel) | 2021 | 34359642 | PubTator, text mining | PubMed |
| Oligodendrocytes and Microglia: Key Players in Myelin Development, Damage and Repair. | Biomolecules | 2021 | 34356682 | PubTator, text mining | PubMed |
| The degree of polymerization and sulfation patterns in heparan sulfate are critical determinants of cytomegalovirus entry into host cells. | PLoS Pathog | 2021 | 34352038 | PubTator, text mining | PubMed |
| Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma. | Int J Oral Sci | 2021 | 34341329 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer. | Front Cell Dev Biol | 2021 | 34336821 | PubTator, text mining | PubMed |
| The Distinct Performances of Ultrasound, Mammograms, and MRI in Detecting Breast Cancer in Patients With Germline Pathogenic Variants in Cancer Predisposition Genes. | Front Oncol | 2021 | 34336698 | PubTator, text mining | PubMed |
| The Role of Epigenetic Changes in the Progression of Alcoholic Steatohepatitis. | Front Physiol | 2021 | 34335299 | PubTator, text mining | PubMed |
| Prevention of chemotherapy-induced premature ovarian insufficiency in mice by scaffold-based local delivery of human embryonic stem cell-derived mesenchymal progenitor cells. | Stem Cell Res Ther | 2021 | 34332643 | PubTator, text mining | PubMed |
| Novel Treatment Pathways in Pulmonary Arterial Hypertension. | Methodist Debakey Cardiovasc J | 2021 | 34326930 | PubTator, text mining | PubMed |
| CMIP interacts with WT1 and targets it on the proteasome degradation pathway. | Clin Transl Med | 2021 | 34323419 | PubTator, text mining | PubMed |
| SNX27-driven membrane localisation of OTULIN antagonises linear ubiquitination and NF-κB signalling activation. | Cell Biosci | 2021 | 34315543 | PubTator, text mining | PubMed |
| Mast cell tryptase enhances wound healing by promoting migration in human bronchial epithelial cells. | Cell Adh Migr | 2021 | 34308764 | PubTator, text mining | PubMed |
| A review of Dynamin 2 involvement in cancers highlights a promising therapeutic target. | J Exp Clin Cancer Res | 2021 | 34294140 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5154/papers?page=55